-
Campbell GR, Watkins JD, Esquieu D, Pasquier E, Loret EP, Spector SA, 2005: The C terminus of HIV-1 Tat modulates the extent of CD178-mediated apoptosis of T cells[J]. J Biol Chem, 280, 38376-38382. doi: 10.1074/jbc.M506630200
-
Cohen J, 2012: The Many States Of HIV in America[J]. Science, 337, 168-171. doi: 10.1126/science.337.6091.168
-
Desfosses Y, Solis M, Sun Q, Grandvaux N, Van Lint C, Burny A, Gatignol A, Wainberg MA, Lin R, Hiscott J, 2005: Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins[J]. J Virol, 79, 9180-9191. doi: 10.1128/JVI.79.14.9180-9191.2005
-
Essex M, 1999: Human immunodeficiency viruses in the developing world[J]. Adv Virus Res, 53, 71-88. doi: 10.1016/S0065-3527(08)60343-7
-
Fiume G, Vecchio E, De Laurentiis A, Trimboli F, Palmieri C, Pisano A, Falcone C, Pontoriero M, Rossi A, Scialdone A, Fasanella Masci F, Scala G, Quinto I, 2012: Human immunodeficiency virus-1 Tat activates NF-kappaB via physical interaction with IkappaB-alpha and p65[J]. Nucleic Acids Res, 40, 3548-3562. doi: 10.1093/nar/gkr1224
-
Gatignol A, Jeang KT, 2000: Tat as a transcriptional activator and a potential therapeutic target for HIV-1[J]. Adv Pharmacol, 48, 209-227. doi: 10.1016/S1054-3589(00)48007-5
-
Geretti AM, 2006: HIV-1 subtypes: epidemiology and significance for HIV management[J]. Curr Opin Infect Dis, 19, 1-7. doi: 10.1097/01.qco.0000200293.45532.68
-
Gibellini D, Vitone F, Schiavone P, Re MC, 2005: HIV-1 tat protein and cell proliferation and survival: a brief review[J]. New Microbiol, 28, 95-109.
-
Grisson RD, Chenine AL, Yeh LY, He J, Wood C, Bhat GJ, Xu W, Kankasa C, Ruprecht RM, 2004: Infectious molecular clone of a recently transmitted pediatric human immunodeficiency virus clade C isolate from Africa: evidence of intraclade recombination[J]. J Virol, 78, 14066-14069. doi: 10.1128/JVI.78.24.14066-14069.2004
-
Howcroft TK, Strebel K, Martin MA, Singer DS, 1993: Repression of MHC class Ⅰ gene promoter activity by two-exon Tat of HIV[J]. Science (New York, N.Y.), 260, 1320-1322. doi: 10.1126/science.8493575
-
Kanki PJ, Hamel DJ, Sankale JL, Hsieh CC, Thior I, Barin F, Woodcock SA, Gueye-Ndiaye A, Zhang E, Montano M, Siby T, Marlink R, NDoye I, Essex ME, MBoup S, 1999: Human immunodeficiency virus type 1 subtypes differ in disease progression[J]. Journal of Infectious Diseases, 179, 68-73. doi: 10.1086/jid.1999.179.issue-1
-
Karn J, 1999: Tackling Tat[J]. J Mol Biol, 293, 235-254. doi: 10.1006/jmbi.1999.3060
-
Lata S, Ali A, Sood V, Raja R, Banerjea AC, 2015: HIV-1 Rev downregulates Tat expression and viral replication via modulation of NAD(P)H:quinine oxidoreductase 1 (NQO1)[J]. Nat Commun, 6, 7244-. doi: 10.1038/ncomms8244
-
Lopez-Huertas MR, Callejas S, Abia D, Mateos E, Dopazo A, Alcami J, Coiras M, 2010: Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon[J]. Nucleic Acids Res, 38, 3287-3307. doi: 10.1093/nar/gkq037
-
Loret EP, Georgel P, Johnson WC Jr., Ho PS, 1992: Circular dichroism and molecular modeling yield a structure for the complex of human immunodeficiency virus type 1 trans-activation response RNA and the binding region of Tat, the trans-acting transcriptional activator[J]. Proc Natl Acad Sci U S A, 89, 9734-9738. doi: 10.1073/pnas.89.20.9734
-
Mishra M, Vetrivel S, Siddappa NB, Ranga U, Seth P, 2008: Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif[J]. Ann Neurol, 63, 366-376. doi: 10.1002/ana.v63:3
-
Ott M, Emiliani S, Van Lint C, Herbein G, Lovett J, Chirmule N, McCloskey T, Pahwa S, Verdin E, 1997: Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway[J]. Science, 275, 1481-1485. doi: 10.1126/science.275.5305.1481
-
Passiatore G, Rom S, Eletto D, Peruzzi F, 2009: HIV-1 Tat C-terminus is cleaved by calpain 1: implication for Tat-mediated neurotoxicity[J]. Biochim Biophys Acta, 1793, 378-387. doi: 10.1016/j.bbamcr.2008.10.010
-
Rana TM, Jeang KT, 1999: Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA[J]. Arch Biochem Biophys, 365, 175-185. doi: 10.1006/abbi.1999.1206
-
Roof P, Ricci M, Genin P, Montano MA, Essex M, Wainberg MA, Gatignol A, Hiscott J, 2002: Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator[J]. Virology, 296, 77-83. doi: 10.1006/viro.2001.1397
-
Saiyed ZM, Gandhi N, Agudelo M, Napuri J, Samikkannu T, Reddy PVB, Khatavkar P, Yndart A, Saxena SK, Nair MPN, 2011: HIV-1 Tat upregulates expression of histone deacetylase-2 (HDAC2) in human neurons: Implication for HIV-associated neurocognitive disorder (HAND)[J]. Neurochemistry International, 58, 656-664. doi: 10.1016/j.neuint.2011.02.004
-
Saxena SK, Tiwari S, Nair MPN, 2012: A Global Perspective on HIV/AIDS[J]. Science, 337, 798-798. doi: 10.1126/science.337.6096.798
-
Sivakumaran H, van der Horst A, Fulcher AJ, Apolloni A, Lin MH, Jans DA, Harrich D, 2009: Arginine methylation increases the stability of human immunodeficiency virus type 1 Tat[J]. J Virol, 83, 11694-11703. doi: 10.1128/JVI.00499-09
-
Smith SM, Pentlicky S, Klase Z, Singh M, Neuveut C, Lu CY, Reitz MS Jr., Yarchoan R, Marx PA, Jeang KT, 2003: An in vivo replication-important function in the second coding exon of Tat is constrained against mutation despite cytotoxic T lymphocyte selection[J]. J Biol Chem, 278, 44816-44825. doi: 10.1074/jbc.M307546200
-
Xiao H, Neuveut C, Benkirane M, Jeang KT, 1998: Interaction of the second coding exon of Tat with human EF-1 delta delineates a mechanism for HIV-1-mediated shut-off of host mRNA translation[J]. Biochem Biophys Res Commun, 244, 384-389. doi: 10.1006/bbrc.1998.8274